IS6857A - Lyfjafræðileg samsetning sem innheldur sítalópram - Google Patents

Lyfjafræðileg samsetning sem innheldur sítalópram

Info

Publication number: IS6857A
Authority: IS; Iceland
Prior art keywords: pharmaceutical composition; composition containing; containing citalopram; citalopram; pharmaceutical
Prior art date: 2001-01-05

Application number

IS6857A

Other languages

English (en)

Inventor

Liljegren Ken

Holm Per

Original Assignee

H. Lundbeck A/S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-05

Filing date

2003-06-23

Publication date

2003-06-23

2003-06-23 Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S

2003-06-23 Publication of IS6857A publication Critical patent/IS6857A/is

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IS6857A 2001-01-05 2003-06-23 Lyfjafræðileg samsetning sem innheldur sítalópram IS6857A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200100016		2001-01-05
PCT/DK2002/000003 WO2002053133A1 (en)	2001-01-05	2002-01-03	Pharmaceutical composition containing citalopram

Publications (1)

Publication Number	Publication Date
IS6857A true IS6857A (is)	2003-06-23

Family

ID=8159961

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6857A IS6857A (is)	2001-01-05	2003-06-23	Lyfjafræðileg samsetning sem innheldur sítalópram

Country Status (22)

Country	Link
US (1)	US20040058989A1 (is)
EP (1)	EP1351667A1 (is)
JP (1)	JP2004517111A (is)
KR (1)	KR20030070088A (is)
CN (1)	CN1484523A (is)
AU (1)	AU2001100195B4 (is)
BG (1)	BG108034A (is)
BR (1)	BR0206272A (is)
CA (1)	CA2358356A1 (is)
CZ (1)	CZ20032119A3 (is)
EA (1)	EA005596B1 (is)
HR (1)	HRP20030546A2 (is)
HU (1)	HUP0302531A3 (is)
IL (1)	IL156547A0 (is)
IS (1)	IS6857A (is)
MX (1)	MXPA03005965A (is)
NO (1)	NO20033073L (is)
PL (1)	PL362358A1 (is)
SK (1)	SK9912003A3 (is)
WO (1)	WO2002053133A1 (is)
YU (1)	YU54503A (is)
ZA (1)	ZA200304860B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2406592C (en) *	2002-10-04	2003-09-30	Duchesnay Inc.	Method of preparing pharmaceutical dosage forms containing multiple active ingredients
MXPA05009886A (es) *	2003-03-14	2006-05-04	Nirmal Mulye	Un proceso para preparar tabletas de liberacion constante.
HU227491B1 (en) *	2003-11-25	2011-07-28	Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag	Tablet containing citalopram hydrogen bromide
EP1901714A2 (en) *	2005-05-20	2008-03-26	Aurobindo Pharma Limited	Pharmaceutical dosage forms comprising escitalopram in form of granules
CN100353939C (zh) *	2006-01-05	2007-12-12	昆明积大制药有限公司	含西酞普兰和环糊精的抗抑郁口服药用组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1358915A (en) *	1971-09-13	1974-07-03	Merck & Co Inc	Directly compressed tablet and composition therefor
GB1526331A (en) *	1976-01-14	1978-09-27	Kefalas As	Phthalanes
GB2357762B (en) *	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
US6977306B2 (en) *	2000-05-02	2005-12-20	Sumitomo Chemical Company, Limited	Citalopram hydrobromide crystal and method for crystallization thereof
CA2353693C (en) *	2000-08-10	2003-07-22	H. Lundbeck A/S	Pharmaceutical composition containing citalopram

2001
- 2001-07-26 AU AU2001100195A patent/AU2001100195B4/en not_active Ceased
- 2001-10-04 CA CA002358356A patent/CA2358356A1/en not_active Abandoned
2002
- 2002-01-03 YU YU54503A patent/YU54503A/sh unknown
- 2002-01-03 HU HU0302531A patent/HUP0302531A3/hu unknown
- 2002-01-03 EP EP02726983A patent/EP1351667A1/en not_active Withdrawn
- 2002-01-03 CZ CZ20032119A patent/CZ20032119A3/cs unknown
- 2002-01-03 SK SK991-2003A patent/SK9912003A3/sk unknown
- 2002-01-03 WO PCT/DK2002/000003 patent/WO2002053133A1/en not_active Application Discontinuation
- 2002-01-03 KR KR10-2003-7008953A patent/KR20030070088A/ko not_active Application Discontinuation
- 2002-01-03 EA EA200300768A patent/EA005596B1/ru not_active IP Right Cessation
- 2002-01-03 BR BR0206272-0A patent/BR0206272A/pt not_active IP Right Cessation
- 2002-01-03 MX MXPA03005965A patent/MXPA03005965A/es unknown
- 2002-01-03 IL IL15654702A patent/IL156547A0/xx unknown
- 2002-01-03 PL PL02362358A patent/PL362358A1/xx not_active Application Discontinuation
- 2002-01-03 CN CNA028034686A patent/CN1484523A/zh active Pending
- 2002-01-03 JP JP2002554084A patent/JP2004517111A/ja not_active Withdrawn
2003
- 2003-06-23 IS IS6857A patent/IS6857A/is unknown
- 2003-06-23 ZA ZA200304860A patent/ZA200304860B/en unknown
- 2003-07-01 US US10/619,743 patent/US20040058989A1/en not_active Abandoned
- 2003-07-04 HR HR20030546A patent/HRP20030546A2/xx not_active Application Discontinuation
- 2003-07-04 NO NO20033073A patent/NO20033073L/no not_active Application Discontinuation
- 2003-07-28 BG BG108034A patent/BG108034A/bg unknown

Also Published As

Publication number	Publication date
EA005596B1 (ru)	2005-04-28
NO20033073D0 (no)	2003-07-04
HUP0302531A2 (hu)	2003-11-28
CN1484523A (zh)	2004-03-24
US20040058989A1 (en)	2004-03-25
IL156547A0 (en)	2004-01-04
BR0206272A (pt)	2003-12-30
YU54503A (sh)	2006-05-25
JP2004517111A (ja)	2004-06-10
WO2002053133A1 (en)	2002-07-11
NO20033073L (no)	2003-07-04
HRP20030546A2 (en)	2005-06-30
CA2358356A1 (en)	2002-01-20
CZ20032119A3 (en)	2004-03-17
SK9912003A3 (en)	2003-12-02
MXPA03005965A (es)	2003-09-05
PL362358A1 (en)	2004-10-18
BG108034A (bg)	2005-02-28
AU2001100195B4 (en)	2001-12-20
KR20030070088A (ko)	2003-08-27
AU2001100195A4 (en)	2001-08-16
HUP0302531A3 (en)	2007-06-28
ZA200304860B (en)	2004-06-30
EP1351667A1 (en)	2003-10-15
EA200300768A1 (ru)	2003-10-30

Publication	Publication Date	Title
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
NO20025450L (no)	2002-11-14	Ny farmasöytisk sammensetning
DK1524266T3 (da)	2007-06-25	Farmaceutisk sammensætning
FI20105657A (fi)	2010-06-10	Farmaseuttisia koostumuksia
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
IS6915A (is)	2003-08-15	Lyfjablanda
BR0210619A (pt)	2006-05-23	composição
EE05020B1 (et)	2008-06-16	Glburiidi ravimkoostis
IS7051A (is)	2003-11-26	Lyfjasamsetningar
IS7081A (is)	2003-12-16	Lyfjablanda
FI20022128A0 (fi)	2002-12-03	Farmaseuttinen koostumus
ITMI20011637A0 (it)	2001-07-27	Composizione farmaceutica contenente citalopram
IS7219A (is)	2004-04-14	Lyfjablanda sem inniheldur (R) -bíkalútamíð
IS6857A (is)	2003-06-23	Lyfjafræðileg samsetning sem innheldur sítalópram
DE60200104D1 (de)	2004-01-15	Desodorierende Zusammensetzung
ITTO20020747A0 (it)	2002-08-23	Composizione
ITTO20020745A0 (it)	2002-08-23	Composizione
EE200200689A (et)	2004-06-15	Ravimkoostised
DK200100203U4 (da)	2003-03-28	Farmaceutisk komposition indeholdende citalopram
ATE271600T1 (de)	2004-08-15	Feste zusammensetzung
FI5468U1 (fi)	2002-07-30	Farmaseuttinen koostumus
SE0100847D0 (sv)	2001-03-09	Novel pharmaceutical composition
SE0101788D0 (sv)	2001-05-21	New composition
SE0101203D0 (sv)	2001-04-03	New composition